CLTS logo

Earth Life Sciences Inc. (CLTS) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cotizando a $, Earth Life Sciences Inc. (CLTS) es una empresa del sector Technology valorada en 0. Calificado con 48/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 17 mar 2026
Puntuación de IA de 48/100

Perfil Tecnológico y Posición Competitiva de Earth Life Sciences Inc. (CLTS)

CEOAngelo Marino
Sede CentralReno, US
Año de la oferta pública inicial (OPI)2003

Earth Life Sciences Inc., based in Reno, Nevada, operates in the transportation software market, offering an online ordering and offline health service matching platform. With a focus on North America, the company navigates the competitive technology landscape with a small market capitalization and negative earnings.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 17 mar 2026

Tesis de Inversión

Earth Life Sciences Inc. presents a speculative investment opportunity due to its presence in the transportation software market and its online/offline health service matching platform. With a market capitalization of $0.00B and a negative P/E ratio of -0.03, the company's financial standing requires careful scrutiny. The company's beta of -55.88 suggests an inverse correlation with the market, but this extreme value warrants further investigation to determine its validity and implications. Potential growth catalysts include expanding its platform's reach within North America and developing new features for its transportation software. However, the company faces significant risks, including competition from established players and the challenges of scaling its operations. Investors should conduct thorough due diligence and assess the company's ability to execute its business plan and achieve profitability.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $0.00B indicates a micro-cap company with high growth potential but also high risk.
  • Negative P/E ratio of -0.03 suggests the company is currently unprofitable.
  • Beta of -55.88 indicates an inverse correlation with the market, requiring further investigation.
  • Operates in the transportation software market, a sector with growth opportunities driven by increasing demand for logistics solutions.
  • Provides an online ordering and offline health service matching platform, potentially tapping into the growing telehealth market.

Competidores y Pares

Fortalezas

  • Operates in growing transportation software market.
  • Offers online and offline health service matching.
  • Presence in North America.

Debilidades

  • Small market capitalization.
  • Negative P/E ratio.
  • Limited information available.

Catalizadores

  • Upcoming: Potential partnerships with healthcare providers to expand the reach of the online health service matching platform.
  • Ongoing: Development of new features for the transportation software platform to attract larger transportation companies.
  • Ongoing: Geographic expansion into emerging markets to diversify revenue streams.

Riesgos

  • Potential: Competition from established players in the transportation software and healthcare technology markets.
  • Potential: Challenges of scaling operations and managing growth.
  • Potential: Regulatory complexities in the healthcare industry.
  • Ongoing: Limited financial disclosure due to OTC Other listing.
  • Ongoing: Low liquidity and high price volatility.

Oportunidades de crecimiento

  • Growth opportunity 1: Expanding the transportation software platform's capabilities to include advanced analytics and real-time tracking features. This could attract larger transportation companies seeking to optimize their operations and reduce costs. The market for transportation management systems is projected to reach $130 billion by 2027, offering a significant opportunity for Earth Life Sciences Inc. to increase its market share. Timeline: 12-18 months.
  • Growth opportunity 2: Developing strategic partnerships with healthcare providers to integrate the online ordering and offline health service matching platform into their existing systems. This could drive adoption and generate recurring revenue streams. The telehealth market is expected to reach $500 billion by 2025, presenting a substantial growth opportunity for Earth Life Sciences Inc. to capitalize on the increasing demand for remote healthcare services. Timeline: 12-24 months.
  • Growth opportunity 3: Geographic expansion beyond North America to target emerging markets with growing transportation and healthcare needs. This could diversify the company's revenue streams and reduce its reliance on a single region. The global transportation and healthcare markets offer significant growth potential, but require careful consideration of local regulations and cultural nuances. Timeline: 24-36 months.
  • Growth opportunity 4: Investing in research and development to create innovative solutions for the transportation and healthcare industries. This could differentiate the company from its competitors and attract new customers. The technology sector is characterized by rapid innovation, and Earth Life Sciences Inc. must continuously develop new products and services to maintain its competitive edge. Timeline: Ongoing.
  • Growth opportunity 5: Implementing a robust marketing and sales strategy to increase brand awareness and generate leads. This could involve online advertising, content marketing, and participation in industry events. Effective marketing is crucial for attracting new customers and driving revenue growth. Earth Life Sciences Inc. needs to develop a targeted marketing plan to reach its key customer segments. Timeline: Ongoing.

Oportunidades

  • Expand transportation software capabilities.
  • Develop strategic partnerships with healthcare providers.
  • Geographic expansion beyond North America.

Amenazas

  • Competition from established players.
  • Challenges of scaling operations.
  • Regulatory complexities in healthcare.

Ventajas competitivas

  • Proprietary transportation software.
  • Established online ordering platform.
  • Network effects from health service matching platform.

Acerca de CLTS

Earth Life Sciences Inc., based in Reno, Nevada, operates within the technology sector, specifically focusing on information technology services. The company's core business revolves around the transportation software market, where it aims to provide innovative solutions for logistics and transportation needs. Additionally, Earth Life Sciences Inc. offers an online ordering and offline health service matching trading platform, potentially targeting the intersection of technology and healthcare services. The company's operations are primarily concentrated in North America, suggesting a regional focus in its market approach. While specific details regarding the company's founding and evolution are not available, its current activities indicate a strategic positioning within the technology sector, leveraging software solutions and online platforms. The combination of transportation software and health service matching suggests a diversified approach, potentially aiming to capitalize on synergies between these two areas. However, the company's small market capitalization of $0.00B indicates that it is still in an early stage of development or faces significant challenges in gaining market traction. Further information on the company's specific products, services, and competitive advantages would be necessary to fully assess its potential within the industry.

Qué hacen

  • Develops transportation software solutions.
  • Provides an online ordering platform.
  • Offers an offline health service matching platform.
  • Connects users with health services.
  • Operates primarily in North America.

Modelo de Negocio

  • Generates revenue through software licensing fees.
  • Potentially earns commissions from online orders.
  • May charge fees for health service matching.

Contexto de la Industria

Earth Life Sciences Inc. operates within the information technology services industry, a dynamic sector characterized by rapid technological advancements and evolving customer needs. The transportation software market, in particular, is experiencing growth driven by the increasing complexity of logistics and supply chain management. The competitive landscape includes established players offering comprehensive transportation management systems, as well as emerging companies focusing on niche solutions. Earth Life Sciences Inc.'s online ordering and offline health service matching platform positions it at the intersection of technology and healthcare, potentially capitalizing on the growing telehealth market. However, the company faces competition from established healthcare technology providers and the challenges of navigating regulatory complexities.

Clientes Clave

  • Transportation companies.
  • Individuals seeking health services.
  • Healthcare providers.
Confianza de la IA: 67% Actualizado: 17 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Earth Life Sciences Inc. (CLTS): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para CLTS.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CLTS.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para CLTS.

MoonshotScore

48/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de CLTS en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Angelo Marino

CEO

Information on Angelo Marino's background is limited. Without further details, it is difficult to assess his prior experience and qualifications. Further research into his career history, education, and previous roles would be necessary to provide a comprehensive overview of his background.

Historial: Due to the lack of available information, Angelo Marino's track record as CEO of Earth Life Sciences Inc. cannot be evaluated. Key achievements, strategic decisions, and company milestones under his leadership are currently unknown.

Información del mercado OTC de CLTS

The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Investing in OTC Other stocks carries significant risks due to the potential for fraud, manipulation, and lack of transparency. These securities are often subject to less regulatory oversight compared to those listed on major exchanges like the NYSE or NASDAQ.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity in OTC Other stocks is typically very low, with wide bid-ask spreads and limited trading volume. This can make it difficult for investors to buy or sell shares without significantly impacting the price. The lack of liquidity also increases the risk of price manipulation and makes it challenging to establish a fair market value for the security. Investors should be prepared for potential delays in executing trades and the possibility of not being able to sell their shares at a desired price.
Factores de riesgo OTC:
  • Limited financial disclosure.
  • Low liquidity and wide bid-ask spreads.
  • Potential for fraud and manipulation.
  • Lack of regulatory oversight.
  • High price volatility.
Lista de verificación de diligencia debida:
  • Verify the company's legal status and registration.
  • Obtain and review any available financial statements.
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's compliance with applicable regulations.
  • Understand the risks associated with investing in OTC Other stocks.
  • Consult with a qualified financial advisor.
Señales de legitimidad:
  • Evidence of a real business operation.
  • Transparent communication with investors.
  • Positive media coverage or industry recognition.
  • Independent audits of financial statements (if available).
  • Active engagement with shareholders.

CLTS Preguntas Frecuentes sobre Acciones de Technology

¿Cuáles son los factores clave para evaluar CLTS?

Earth Life Sciences Inc. (CLTS) actualmente tiene una puntuación IA de 48/100, indicando puntuación baja. Fortaleza clave: Operates in growing transportation software market.. Riesgo principal a monitorear: Potential: Competition from established players in the transportation software and healthcare technology markets.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de CLTS?

CLTS actualmente puntúa 48/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de CLTS?

Los precios de CLTS se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre CLTS?

La cobertura de analistas para CLTS incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en CLTS?

Las categorías de riesgo para CLTS incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Competition from established players in the transportation software and healthcare technology markets.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de CLTS?

La relación P/E para CLTS compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está CLTS sobrevalorada o infravalorada?

Determinar si Earth Life Sciences Inc. (CLTS) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de CLTS?

Earth Life Sciences Inc. (CLTS) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Limited information available on Earth Life Sciences Inc.
  • OTC Other listing indicates higher risk.
Fuentes de datos

Popular Stocks